Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A. Braun, Catherine J. Wu, Shuqiang Li et al.|Cancer Cell|2021Cited by 515
Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinomaDavid A. Braun, Toni K. Choueiri, Ziad Bakouny et al.|Nature Reviews Clinical Oncology|2021Cited by 382
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, Srinivas R. Viswanathan, David A. Braun et al.|Nature Communications|2021Cited by 167
Integrative clinical and molecular characterization of translocation renal cell carcinomaZiad Bakouny, Srinivas R. Viswanathan, Ananthan Sadagopan et al.|Cell Reports|2022Cited by 115
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell CarcinomaLaure Hirsch, Toni K. Choueiri, Nieves Martínez Chanzá et al.|JAMA Oncology|2021Cited by 95